XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Compensation
3 Months Ended
Mar. 31, 2017
Share-Based Compensation  
Share-Based Compensation

Note 12 — Share-Based Compensation

 

The Company’s 2004 and 2012 share-based compensation plans are long-term retention plans intended to attract, retain, and provide incentives for key employees and non-employee directors in the form of incentive and non-qualified stock options, restricted stock, and restricted stock units (“RSUs”).

 

Stock Options

 

With the exception of non-qualified stock options granted to directors under the 2004 and 2012 plans, which in some cases may be exercised at any time prior to expiration and in some other cases may be exercised at intervals less than a year following the grant date, incentive stock options granted under the plans may not be exercised in whole or in part within a year following the date of the grant, as these incentive stock options become exercisable in 25% increments pro ratably over the four-year period following the grant date.  The options are granted at an exercise price at least equal to the fair value of the common stock at the date of grant and expire ten years from the date of grant.  No options were granted under the 2004 plan after January 26, 2012, and the 2004 plan is closed other than for any options still unexercised and outstanding. The 2012 plan is the only plan from which new share-based compensation grants may be issued.  It is the Company’s policy to grant options out of the 1,684,000 shares registered under the 2012 plan, of which no more than 817,476 shares can be granted as restricted stock or RSUs.

Activity in the Company’s stock option plans is summarized in the following table.  All information has been retroactively adjusted for stock dividends and stock splits.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

Average

 

Aggregate

 

 

 

 

 

Average

 

Remaining

 

Intrinsic

 

 

    

Shares

    

Price

    

(Yrs.)

    

(000's)

 

Outstanding at  January 1

 

246,535

 

$

42.53

 

 

 

 

 

 

Granted

 

33,634

 

 

91.23

 

 

 

 

 

 

Exercised

 

(9,002)

 

 

34.14

 

 

 

 

 

 

Outstanding at March 31

 

271,167

 

 

48.85

 

5.38

 

$

11,049

 

Exercisable at March 31

 

201,180

 

 

39.26

 

4.13

 

$

10,077

 

Weighted-average fair value of options granted during the year

 

$
35.42

 

 

 

 

 

 

 

 

 

 

The fair value of options is estimated at the date of grant using the Black-Scholes option pricing model and expensed over the options’ vesting periods.  The following weighted-average assumptions were used in valuing options issued:

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended  March 31,

 

    

2017

 

    

2016

 

 

 

Dividend yield

 

1.40

 %  

 

1.60

%  

 

 

Expected life

 

8.5

years  

 

8.5

years  

 

 

Expected volatility

 

37.2

%  

  

40.6

%  

 

 

Risk-free interest rate

 

2.43

%  

  

1.90

%  

 

 

 

As of March 31,  2017, there was $1.9 million of total unrecognized compensation cost related to nonvested stock option grants under the plans.  The cost is expected to be recognized over a weighted-average period of 1.88 years as of March 31,  2017.  The total fair value of shares vested during the three months ended March 31,  2017 was $578,000.

 

Restricted Stock

 

The Company from time-to-time also grants shares of restricted stock to key employees and non-employee directors.  These awards help align the interests of these employees and directors with the interests of the shareholders of the Company by providing economic value directly related to increases in the value of the Company’s stock.  The value of the stock awarded is established as the fair market value of the stock at the time of the grant.  The Company recognizes expenses, equal to the total value of such awards, ratably over the vesting period of the stock grants.  Restricted stock grants to employees typically “cliff vest” after four years.  Grants to non-employee directors typically vest within a 12-month period.

 

All restricted stock agreements are conditioned upon continued employment. Termination of employment prior to a vesting date, as described below, would terminate any interest in non-vested shares. Prior to vesting of the shares, as long as employed by the Company, the key employees and non-employee directors will have the right to vote such shares and to receive dividends paid with respect to such shares. All restricted shares will fully vest in the event of change in control of the Company or upon the death of the recipient.

 

Nonvested restricted stock for the three months ended March 31, 2017 is summarized in the following table.  All information has been retroactively adjusted for stock dividends and stock splits.

 

 

 

 

 

 

 

 

 

    

 

    

Weighted-

 

 

 

 

 

Average

 

 

 

 

 

Grant-Date

 

Restricted Stock

 

Shares

 

Fair Value

 

Nonvested at January 1, 2017

 

183,014

 

$

51.88

 

Granted

 

11,273

 

 

91.22

 

Vested

 

(44,011)

 

 

43.49

 

Nonvested at March 31, 2017

 

150,276

 

 

57.29

 

 

As of March 31,  2017, there was $5.3 million of total unrecognized compensation cost related to nonvested restricted stock granted under the plans.  This cost is expected to be recognized over a weighted-average period of 2.64 years as of March 31,  2017.  The total fair value of shares vested during the three months ended March 31,  2017 was $2.0 million.

 

Restricted Stock Units

 

The Company from time-to-time also grants performance and discretionary RSUs to key employees.  These awards help align the interests of these employees with the interests of the shareholders of the Company by providing economic value directly related to the performance of the Company.  Some performance RSU grants contain a three-year performance period while others contain a one-year performance period and a time vested requirement (generally four years from grant date).  The Company communicates threshold, target, and maximum performance RSU awards and performance targets to the applicable key employees at the beginning of a performance period.  Discretionary RSUs are based upon prior performance and typically cliff-vest from the grant date over four years.  Dividends are not paid in respect to the awards during the performance or the vesting period.  The value of the RSUs awarded is established as the fair market value of the stock at the time of the grant.  The Company recognizes expenses on a straight-line basis typically over the performance and vesting periods based upon the probable performance target that will be met.  For the three months ended March 31,  2017, the Company accrued for 80% of the RSUs granted, based on Management’s expectations of performance.

 

Nonvested RSUs for the three months ended March 31,  2017 is summarized in the following table.

 

 

 

 

 

 

 

 

 

    

 

    

Weighted-

 

 

 

 

 

Average

 

 

 

 

 

Grant-Date

 

Restricted Stock Units

 

Shares

 

Fair Value

 

Nonvested at January 1, 2017

 

107,876

 

$

66.37

 

Granted

 

61,193

 

 

89.40

 

LTIP Adjustment

 

(3,951)

 

 

63.93

 

Nonvested at March 31, 2017

 

165,118

 

 

74.96

 

 

As of March 31,  2017, there was $6.2 million of total unrecognized compensation cost related to nonvested RSUs granted under the plan.  This cost is expected to be recognized over a weighted-average period of 2.2 years as of March 31, 2017.  The total fair value of RSUs vested during the three months ended March 31,  2017 was $2.3 million.  During the three months ended March 31, 2017, 57,455 vested restricted stock units were issued to the participants in the 2014 Long-Term Incentive Plan.